Raxone by Santhera Pharmaceuticals

This product has been studied in clinical research. Based on this research, this product's Effectiveness Rating is:

POSSIBLY EFFECTIVE

• Muscular dystrophy
• Leber hereditary optic neuropathy

INSUFFICIENT RELIABLE EVIDENCE to RATE

• Multiple sclerosis (MS)